LKFT — Lakefront Biotherapeutics NV
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.
Performance
Technicals
Others in Healthcare
Measured signals that fired on LKFT
| date | signal | measured base rate |
|---|---|---|
| 2026-08-03 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-05-07 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-04-07 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| GILEAD SCIENCES, INC. | 501.2M | 16.7M |
| TANG CAPITAL MANAGEMENT LLC | 113.6M | 3.8M |
| Madison Avenue Partners, LP | 74.0M | 2.5M |
| EcoR1 Capital, LLC | 50.0M | 1.7M |
| Prosight Management, LP | 46.5M | 1.6M |
| AMERIPRISE FINANCIAL INC | 42.7M | 1.4M |
| DME Capital Management, LP | 14.5M | 482.7K |
| SEGALL BRYANT & HAMILL, LLC | 12.8M | 426.4K |
| Point72 Asset Management, L.P. | 10.0M | 332.1K |
| RENAISSANCE TECHNOLOGIES LLC | 9.5M | 315.4K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 6-K | 2026-08-18 | 2026-08-18 | on EDGAR ↗ |
| 6-K | 2026-08-12 | 2026-08-12 | on EDGAR ↗ |
| 6-K | 2026-08-12 | 2026-08-12 | on EDGAR ↗ |
| 6-K | 2026-08-04 | 2026-08-04 | on EDGAR ↗ |
| 6-K | 2026-07-28 | 2026-07-28 | on EDGAR ↗ |
| 6-K | 2026-07-21 | 2026-07-21 | on EDGAR ↗ |
| 6-K | 2026-07-15 | 2026-07-14 | on EDGAR ↗ |
| 6-K | 2026-07-13 | 2026-07-13 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Lakefront Biotherapeutics NV (LKFT) filed form 6-K · 2026-08-18 · SEC EDGAR
Ask the AI about LKFT
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →